New Market Opportunities for CPG While the emergence of GLP-1 drugs poses perceived challenges to the food industry, it simultaneously brings forth a plethora of opportunities
If you're currently on a GLP-1 medication semaglutide, tirzepatide, liraglutide, dulaglutide, or any GLP-1 receptor agonist and you're concerned about nutrient gaps from reduced food intake, this is built for you
doi: 10.1016/j.phymed.2024.155722 121 DengJWangESJenkinsRWLiSDriesRYatesKet al
Wegovy is approved for weight loss in overweight adults or those diagnosed with obesity
The market also faces increasing competitive pressure as multiple pharmaceutical companies pursue innovative therapies for diabetes and obesity
The outer third of the meniscus has blood supply (the "red zone") and responds better to healing interventions than the inner "white zone." Primary site: Inject along the joint line on the side of the tear